Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 1091-1099

  Huang, Xin ^a   Chen, Yaping ^a   Chung, Chun Shiang ^a   Yuan, Zhenglong ^a   Monaghan, Sean F ^a   Wang, Fei ^a   Ayala, Alfred ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRAMMED DEATH 1 LIGAND 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BONE MARROW CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; INNATE IMMUNITY; MALE; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SEPSIS; UPREGULATION;

ANIMALS; ANTIGENS, CD274; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; IMMUNITY, INNATE; INTESTINAL PERFORATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MYELOID CELLS; NEUTROPHILS; PERITONITIS; PHAGOCYTOSIS; PROGNOSIS; PROGRAMMED CELL DEATH 1 RECEPTOR; SEPSIS; UP-REGULATION;

EID: 84893381574     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302252     Document Type: Article

References (40)

1. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554.
2. Angus, D. C. 2010. The lingering consequences of sepsis: a hidden public health disaster? JAMA 304: 1833-1834.
3. Bosmann, M., and P. A. Ward. 2013. The inflammatory response in sepsis. Trends Immunol. 34: 129-136.
4. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
5. Wenzel, R. P., and M. B. Edmond. 2012. Septic shock -evaluating another failed treatment. N. Engl. J. Med. 366: 2122-2124.
6. Cai, B., E. A. Deitch, and L. Ulloa. 2010. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010: 642462.
7. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
8. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
9. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
10. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
11. Topalian, S. L., C. G. Drake, and D. M. Pardoll. 2012. Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity. Curr. Opin. Immunol. 24: 207-212.
12. Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236: 219-242.
13. Brown, K. E., G. J. Freeman, E. J. Wherry, and A. H. Sharpe. 2010. Role of PD-1 in regulating acute infections. Curr. Opin. Immunol. 22: 397-401.
14. Huang, X., F. Venet, Y. L. Wang, A. Lepape, Z. Yuan, Y. Chen, R. Swan, H. Kherouf, G. Monneret, C. S. Chung, and A. Ayala. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 106: 6303-6308.
15. Dong, H., G. Zhu, K. Tamada, D. B. Flies, J. M. van Deursen, and L. Chen. 2004. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20: 327-336.
16. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151.
17. Ayala, A., S. M. Karr, T. A. Evans, and I. H. Chaudry. 1997. Factors responsible for peritoneal granulocyte apoptosis during sepsis. J. Surg. Res. 69: 67-75.
18. Ebong, S. J., D. R. Call, G. Bolgos, D. E. Newcomb, J. I. Granger, M. O'Reilly, and D. G. Remick. 1999. Immunopathologic responses to non-lethal sepsis. Shock 12: 118-126.
19. Craciun, F. L., E. R. Schuller, and D. G. Remick. 2010. Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J. Immunol. 185: 6930-6938.
20. Semeraro, N., C. T. Ammollo, F. Semeraro, and M. Colucci. 2012. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 129: 290-295.
21. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, R. E. Schmieg, Jr., J. J. Hui, K. C. Chang, D. F. Osborne, B. D. Freeman, J. P. Cobb, T. G. Buchman, and I. E. Karl. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166: 6952-6963.
22. Lyn-Kew, K., and T. J. Standiford. 2008. Immunosuppression in sepsis. Curr. Pharm. Des. 14: 1870-1881.
23. Coopersmith, C. M., P. E. Stromberg, W. M. Dunne, C. G. Davis, D. M. Amiot, II, T. G. Buchman, I. E. Karl, and R. S. Hotchkiss. 2002. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287: 1716-1721.
24. Hotchkiss, R. S., and D. W. Nicholson. 2006. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6: 813-822.
25. Gupta, A., D. T. Berg, B. Gerlitz, G. R. Sharma, S. Syed, M. A. Richardson, G. Sandusky, J. G. Heuer, E. J. Galbreath, and B. W. Grinnell. 2007. Role of protein C in renal dysfunction after polymicrobial sepsis. J. Am. Soc. Nephrol. 18: 860-867.
26. Bone, R. C. 1996. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 24: 163-172.
27. Riella, L. V., A. M. Paterson, A. H. Sharpe, and A. Chandraker. 2012. Role of the PD-1 pathway in the immune response. Am. J. Transplant. 12: 2575-2587.
28. Hutchins, N. A., F. Wang, Y. Wang, C. S. Chung, and A. Ayala. 2013. Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1. J. Leukoc. Biol. 94: 963-970.
29. Crawford, A., and E. J. Wherry. 2009. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr. Opin. Immunol. 21: 179-186.
30. Kaufmann, D. E., and B. D. Walker. 2009. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182: 5891-5897.
31. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545.
32. Lichtenstern, C., T. Brenner, H. J. Bardenheuer, and M. A. Weigand. 2012. Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr. Opin. Infect. Dis. 25: 328-336.
33. Andaluz-Ojeda, D., F. Bobillo, V. Iglesias, R. Almansa, L. Rico, F. Gandía, S. Resino, E. Tamayo, R. O. de Lejarazu, and J. F. Bermejo-Martin. 2012. A combined score of pro-And anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 57: 332-336.
34. Mera, S., D. Tatulescu, C. Cismaru, C. Bondor, A. Slavcovici, V. Zanc, D. Carstina, and M. Oltean. 2011. Multiplex cytokine profiling in patients with sepsis. APMIS 119: 155-163.
35. Panacek, E. A., J. C. Marshall, T. E. Albertson, D. H. Johnson, S. Johnson, R. D. MacArthur, M. Miller, W. T. Barchuk, S. Fischkoff, M. Kaul, et al; Monoclonal Anti-TNF: a Randomized Controlled Sepsis Study Investigators. 2004. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab9)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. 32: 2173-2182.
36. El-Maghraby, S. M., M. M. Moneer, M. M. Ismail, L. M. Shalaby, and H. A. El-Mahallawy. 2007. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J. Pediatr. Hematol. Oncol. 29: 131-136.
37. Bozza, F. A., J. I. Salluh, A. M. Japiassu, M. Soares, E. F. Assis, R. N. Gomes, M. T. Bozza, H. C. Castro-Faria-Neto, and P. T. Bozza. 2007. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care 11: R49.
38. Heper, Y., E. H. Akalin, R. Mistik, S. Akgoz, O. Tore, G. Goral, B. Oral, F. Budak, and S. Helvaci. 2006. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-Acquired sepsis, severe sepsis, and septic shock. Eur. J. Clin. Microbiol. Infect. Dis. 25: 481-491.
39. Pierrakos, C., and J. L. Vincent. 2010. Sepsis biomarkers: a review. Crit. Care 14: R15.
40. Clatworthy, M. R., and K. G. Smith. 2004. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J. Exp. Med. 199: 717-723.